Sound waves may open Brain's shield to attack deadly tumor

NCT ID NCT07562971

NEW Not yet recruiting Disease control Sponsor: UMC Utrecht Source: ClinicalTrials.gov ↗

First seen May 17, 2026 · Last updated May 17, 2026

Summary

This study tests a new way to treat a rare, aggressive brain tumor called diffuse midline glioma (DMG). The tumor sits deep in the brainstem, where a natural barrier often blocks chemotherapy from working. Researchers will use focused ultrasound to temporarily open that barrier, allowing more chemo to reach the tumor. The study includes 20 children and adults and aims to see if the procedure is safe and may help slow tumor growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Princess Maxima Center for pediatric oncology

    Utrecht, 3584 CS, Netherlands

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UMC Utrecht

    Utrecht, 3584 CX, Netherlands

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.